Donepezil and athetosis in an elderly patient with Alzheimer's disease [6]

Journal of the American Geriatrics Society

Volumn 51, Issue 6, 2003, Pages 889-890

  Tanaka, Makoto ^b   Yokode, Masayuki ^b   Kita, Toru ^b   Matsubayashi, Kozo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; ATHETOSIS; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0038315139     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2389.2003.51281.x     Document Type: Letter

References (6)

1. Doody RS, Geldmacher DS, Gordon B et al. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001;58:427-433.
2. Mohs RC, Doody RS, Morris JC et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001;57:481-488.
3. Winblad B, Engedal K, Soininen H et al. A 1-year, randomized, placebocontrolled study of donepezil in patients with mild to moderate AD. Neurology 2001;57:489-495.
4. Mega MS, Masterman DM, O'Connor SM et al. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 1999;56:1388-1393.
5. Weiner MF, Martin-Cook K, Foster BM et al. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry 2000;61:487-492.
6. Adams RD, Victor M, Ropper AH. Abnormalities of movement and posture due to disease of the basal ganglia. In: Principles of Neurology, 6th Ed. New York: McGraw-Hill, 1997, pp. 64-83.